{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:20Z","timestamp":1790018060894,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IFB-Tx"},{"DOI":"10.13039\/100009139","name":"German Centre for Infection Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hannover Biomedical Research School"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jhep.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:03:58Z","timestamp":1562612638000},"page":"889-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2638-2380","authenticated-orcid":false,"given":"Amare","family":"Aregay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Owusu Sekyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Deterding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Berkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sarrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Peter","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-8001","authenticated-orcid":false,"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.06.025_b0005","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.gastro.2018.08.061","article-title":"Insights From antiviral therapy into immune responses to hepatitis B and C virus infection","volume":"156","author":"Rehermann","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.025_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2014.08.008","article-title":"A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C","volume":"62","author":"Owusu Sekyere","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2019.06.025_b0025","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/JVI.01499-09","article-title":"Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution","volume":"84","author":"Kasprowicz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.025_b0030","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","article-title":"Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection","volume":"169","author":"Wedemeyer","year":"2002","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.jhep.2019.06.025_b0035","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2019.06.025_b0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.06.025_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0050","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/S0140-6736(15)60605-5","article-title":"Towards interferon-free treatment for all HCV genotypes","volume":"385","author":"Wedemeyer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.06.025_b0055","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jhep.2018.07.002","article-title":"Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection","volume":"69","author":"Vermehren","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0060","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/eji.201646447","article-title":"Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy","volume":"46","author":"Hengst","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2019.06.025_b0065","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/s41467-018-04685-9","article-title":"Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity","volume":"9","author":"Strunz","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2019.06.025_b0070","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-acting antiviral-induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2019.06.025_b0075","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.025_b0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiv391","article-title":"Immunological analysis during interferon-free therapy for chronic hepatitis C virus infection reveals modulation of the natural killer cell compartment","volume":"213","author":"Spaan","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2019.06.025_b0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep4.1166","article-title":"Early and late changes in natural killer cells in response to ledipasvir\/sofosbuvir treatment","volume":"2","author":"Golden-Mason","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2019.06.025_b0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"Burchill","year":"2015","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.jhep.2019.06.025_b0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fimmu.2015.00270","article-title":"Type I interferon elevates co-regulatory receptor expression on CMV- and EBV-specific CD8 T cells in chronic hepatitis C","volume":"6","author":"Owusu Sekyere","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2019.06.025_b0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fimmu.2018.00510","article-title":"Human gammadelta T cell receptor repertoires in peripheral blood remain stable despite clearance of persistent hepatitis C virus infection by direct-acting antiviral drug therapy","volume":"9","author":"Ravens","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2019.06.025_b0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0110","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2019.06.025_b0115","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/JVI.00093-11","article-title":"Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naive-precursor frequency","volume":"85","author":"Schmidt","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.025_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JVI.02242-14","article-title":"Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection","volume":"89","author":"Nitschke","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.025_b0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.06.025_b0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.06.025_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2019.06.025_b0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2019.06.025_b0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.06.025_b0150","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2019.06.025_b0155","doi-asserted-by":"crossref","first-page":"328rv324","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7\u2013H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2019.06.025_b0165","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.06.025_b0170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07916","article-title":"Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients","volume":"4","author":"Alanio","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.jhep.2019.06.025_b0175","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jhep.2019.06.025_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2019.06.025_b0185","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2016.09.004","article-title":"HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe","volume":"66","author":"Ingiliz","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/L15-0485","article-title":"Hepatitis C virus treatment and persons who inject drugs","volume":"164","author":"Grebely","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0200","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.28309","article-title":"Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral","volume":"63","author":"Callendret","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.06.025_b0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jhep.2014.11.009","article-title":"Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-beta induction by efficient MAVS cleavage","volume":"62","author":"Welsch","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.06.025_b0215","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/liv.13869","article-title":"Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases","volume":"38","author":"Aregay","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.06.025_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000490360","article-title":"HCC immune surveillance and antiviral therapy of hepatitis C virus infection","volume":"8","author":"Owusu Sekyere","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhep.2019.06.025_b0225","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1128\/jvi.68.7.4700-4704.1994","article-title":"Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice","volume":"68","author":"Battegay","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2019.06.025_b0230","first-page":"129","article-title":"IL-10: achieving balance during persistent viral infection","volume":"380","author":"Ng","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2019.06.025_b0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.06.025_b0240","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0245","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mito.2007.08.001","article-title":"Convergence of multiple signaling pathways is required to coordinately up-regulate mtDNA and mitochondrial biogenesis during T cell activation","volume":"7","author":"D'Souza","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2019.06.025_b0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20010659","article-title":"Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression","volume":"195","author":"Devadas","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.06.025_b0255","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr Biol: CB"},{"key":"10.1016\/j.jhep.2019.06.025_b0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.immuni.2013.02.005","article-title":"Mitochondrial ROS fire up T cell activation","volume":"38","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.06.025_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"Gardiner","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.06.025_b0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2013.02.022","article-title":"A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C","volume":"59","author":"Sangro","year":"2013","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819303976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819303976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:37:18Z","timestamp":1759174638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819303976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0168827819303976"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.06.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}